Genetic diversity of human RNase 8
- Calvin C Chan†1,
- Jennifer M Moser†1, 2,
- Kimberly D Dyer1,
- Caroline M Percopo1 and
- Helene F Rosenberg1, 3Email author
© Chan et al; licensee BioMed Central Ltd. 2012
Received: 1 June 2011
Accepted: 24 January 2012
Published: 24 January 2012
Ribonuclease 8 is a member of the RNase A family of secretory ribonucleases; orthologs of this gene have been found only in primate genomes. RNase 8 is a divergent paralog of RNase 7, which is lysine-enriched, highly conserved, has prominent antimicrobial activity, and is expressed in both normal and diseased skin; in contrast, the physiologic function of RNase 8 remains uncertain. Here, we examine the genetic diversity of human RNase 8, a subject of significant interest given the existence of functional pseudogenes (coding sequences that are otherwise intact but with mutations in elements crucial for ribonucleolytic activity) in non-human primate genomes.
RNase 8 expression was detected in adult human lung, spleen and testis tissue by quantitative reverse-transcription PCR. Only two single-nucleotide polymorphisms and four unique alleles were identified within the RNase 8 coding sequence; nucleotide sequence diversity (π = 0.00122 ± 0.00009 per site) was unremarkable for a human nuclear gene. We isolated transcripts encoding RNase 8 via rapid amplification of cDNA ends (RACE) and RT-PCR which included a distal potential translational start site followed by sequence encoding an additional 30 amino acids that are conserved in the genomes of several higher primates. The distal translational start site is functional and promotes RNase 8 synthesis in transfected COS-7 cells.
These results suggest that RNase 8 may diverge considerably from typical RNase A family ribonucleases and may likewise exhibit unique function. This finding prompts a reconsideration of what we have previously termed functional pseudogenes, as RNase 8 may be responding to constraints that promote significant functional divergence from the canonical structure and enzymatic activity characteristic of the RNase A family.
RNase A ribonucleases are vertebrate proteins with unique tertiary structure and specific enzymatic activity [1, 2]. Bovine pancreatic ribonuclease, or RNase A, is the prototype and founding member of this family, which includes enzymatically-active proteins from humans, multiple mammalian species, birds, and vertebrate fish [3–5]. Initial publication of the complete sequence of the human genome led to the discovery of several highly divergent orthologs of RNase A (RNases 9-13) that seemed to have lost elements crucial for enzymatic activity [6, 7]. Even among the more prototypical RNase A ribonucleases, such as eosinophil cationic protein (RNase 3) and avian leukocyte RNase A-2, ribonuclease activity is not an essential component of their prominent antimicrobial properties [8, 9]. These and related findings have suggest that active evolutionary constraints may not be directed toward maintaining optimal levels of enzymatic activity, and that the RNase A genes themselves may actually be serving more as evolutionary scaffolds, the genetic raw material for ongoing diversification [9, 10]. Examples of this concept include the functional compartmentalization of the digestive ribonucleases RNase 1 and 1B of herbivorous primate, douc langur ; the species-limited duplication of bovine RNase A leading to bovine seminal RNase ; the identification of multiple rodent RNase 1 clusters ; and the dramatic and extensive diversification of both primate and rodent eosinophil ribonucleases [14–16].
RNases 7 and 8 are among the more recently discovered of the RNase A ribonucleases. RNase 7 was described by Harder and Schröeder  as an antimicrobial protein from human skin and also by Zhang and colleagues  who located the RNase 7 open reading frame in the first draft release of the human genome sequence. RNase 7 is expressed in primary keratinocytes in response to proinflammatory stimuli , has dramatic activity against numerous bacterial and some fungal pathogens [17, 19, 20], and has been associated with several cutaneous disease states [21, 22]. In contrast to the arginine-rich antimicrobial RNases ECP and leukocyte RNase A-2, RNase 7 is cationic due to an abundance of lysine residues. Huang and colleagues  have shown that multiple lysines interact with the bacterial membrane to promote antimicrobial activity; recently, P. aeruginosa outer membrane protein 1 has also been documented as a specific target . RNase 7 coding sequences have been identified in recent releases of the chimpanzee (P. troglodytes) and macaque (M. mulatta) genomes, at 99% and 93% encoded amino acid sequence identities to the human RNase 7, respectively. There is no ortholog of RNase 7 in the mouse genome.
Human RNase 8 was also identified as an open reading frame in the first release of the human genome sequence . In our original report, we noted that RNase 8 was not as cationic as RNase 7, and had an atypical cysteine structure later shown by Zhang  to have evolved by a gain-and-loss, or disulfide shuffling mechanism. We evaluated RNase 8 sequences from 10 primate species, and found several examples in which otherwise full length sequences encoded alterations in elements essential to ribonuclease structure and/or activity, a feature we termed "functional pseudogenes" . This finding appears to be unique to RNase 8; no evidence of functional pseudogenization has emerged in similar studies of the eosinophil ribonucleases, angiogenin, or RNase 6 [14, 27, 28].
Given this unusual pattern of diversification, we questioned whether we might detect similar pseudogenized alleles of RNase 8 within the human population. We explored this possibility by isolating and sequencing coding alleles from characterized panels of genomic DNA from diverse human sources. Here we present our findings on the genetic diversity of human RNase 8. Equally interesting, we present a novel and previously unrecognized distal translational start site encoded within the transcript, which has prompted us to reconsider RNase 8 expression and function.
Expression of RNase 8 in human tissues
The coding sequence of human RNase 8 includes two SNPs and an extended amino terminus
Two non-silent SNPs were identified within the extended RNase 8 coding sequence. One SNP (C86 ↔ T; rs12434982) results in alternating S-30/L within the extended amino terminal sequence; the second SNP (T121 ↔ C) alters the sequence of the hydrophobic segment, S-18 /P (rs12437266; ). Other than the aforementioned, previously unreported single allele (C37/R), there were no SNPs identified in the ribonuclease domain of RNase 8. The predominant S-30S-18 variant accounts for 54% of the alleles examined; the remaining variants constitute 17% (S-30P-18), 11% (L-30S-18), and 18% (L-30P-18) of the total Figure 2B. Nucleotide sequence diversity was calculated at π = 0.00122 ± 0.00009 per site.
Characterization of the transcripts encoding human RNase 8
Amplification, sequencing and site-directed mutagenesis primers for RNase 8
5'- CAC ATT GCC CTG CAA TAA CTG GCT -3'
5'- AGG TTG AGT GTG TGG GAG GGA AAT -3'
RNase 8 Fi
5'- TCA CTC TGT TCC ACT GTC TCC CTT -3'
RNase 8 Ri
5'- AGT CTG CAG AGT GTG AG GTG GAA -3'
Human RNase 8 nested RACE (human spleen cDNA)
rcRN8 (3' → 5')
5'-CAA CTT TAT CCA AGT GCA CAG GA-3'
R85Rn (3' → 5')
5'-CTG GGT CAC CCT GTT GTG GAG-3'
Human RNase 8 nested reverse-trancriptase PCR (RT-PCR)
5'-ACA ATA GAA TGC CAG GGG TGT TCA-3'
5'-CAA CTT TAT CCA AGT GCA CAG GA-3'
5'-CAT TGC CCT GCA ATA ACT GGC TT-3'
5'-CTG GGT CAC CCT GTT GTG GAG-3'
Human RNase 8 quantitative RT-PCR
5'- CAT AGC CTG CAA GAA TAG CTG TAA AA-3'
5'- TCA CCC ATG GTC AGG GAC AT-3'
6FAM-CTG CCA CCA GAG CCA CGG GC-TAMRA
Nested primate genome RNase 8
5'-GCC AGG GGT GTT CAA TAT CTT AG-3'
5'-AGG TTG AGT GTG TGG GAG GGA AAT-3'
5'-CAC ATT GCC CTG CAA TAA CTG GCT-3'
5'-AGT CTG CAG AGT GTG AGG TGG AAC-3'
RNase 8 expression plasmids
5'-AAG CTT ATT GCC CTG CAA TAA CTG GCT TAG GGT-3'
5'-CTC CTC CTC TCT AGA GAC AAC TTT ATC CAA GTG CAC A-3'
5'-AAG CTT ACT CTG TTC CAC TGT CTC CCT TAA GAG AG-3'
5'-CTC CTC CTC TCT AGA GAC AAC TTT ATC CAA GTG CAC A-3'
5'-TCT CCC TTA AGA GAG ATA GCA CCG GCC AGA GCA-3'
5'-TGC TCT GGC CGG TGC TAT CTC TCT TAA GGG AGA-3'
Extended amino termini in primate RNase 8s
Characterization of the two translational start sites
RNase 8 is closely related to RNase 7, but it is clearly subject to different evolutionary constraints. RNase 7 is a prototypical RNase A ribonuclease, as it is enzymatically active against standard RNA substrates, includes an H -K- H catalytic triad, and eight canonically-spaced cysteines that generate disulfide bonds that define the tertiary structure [17, 18]. Although no formal evolutionary analysis has been performed on the RNase 7 lineage, a comparison of available coding sequences from human and genome builds of chimpanzee and macaque  suggests that this lineage is highly conserved over time. In contrast, in an earlier study of RNase 8, we documented substantial interspecies divergence (1.3 × 10-9 substitutions/site/year), and we noted the existence of true pseudogenes, with significant truncations in encoded polypeptides in the genomes of several higher primates, including gorilla (G. gorilla) and baboon (P. hamadryas). We also identified RNase 8 functional pseudogenes; these were genes that encoded full length RNase 8 polypeptides but with mutations in crucial structural or catalytic residues . Examples include RNase 8s from the tamarin (S. oedipus), in which the first catalytic histidine (H) is mutated to aspartic acid (D), and likewise the African green monkey (C. aethiops), in which a structural cysteine is lost. We embarked on the present study in large part to determine whether alleles encoding pseudogenes (true or functional) might be circulating within the human population. Interestingly, although detected in only one human allele among those in our study, we did identify a C37/R polymorphism similar to that found in the C. aethiops gene. Aside from that one isolate, only two main SNPs were identified within the coding sequence of RNase 8, and although the nucleotide sequence diversity was somewhat greater than that observed for RNase 7 (π = 0.00073 ± 0.00022; unpublished data), the value calculated for RNase 8, π = 0.00122 ± 0.00009 per site, is within the normal range for nuclear genes , and is similar to values determined for the functional eosinophils RNases, the eosinophil-derived neurotoxin (EDN/RNase 2; π = 0.00063 ± 0.0001) and eosinophil cationic protein (ECP/RNase 3; π = 0.00113 ± 0.00006) .
However, perhaps most intriguing of all is the elucidation of the distal translational start site and putative extended open reading frame of RNase 8; the original start site was identified based on sequence homology to RNase 7  and other RNase A family ribonucleases. This amino terminal extension is unique and breaks the paradigm for the prototypical RNase A ribonucleases, which, as a group, are granule and/or secretory proteins, with amino terminal hydrophobic signal sequences that direct the nascent polypeptides through the ER/Golgi for post-translational processing prior to release . In contrast to the hydrophobic quality of amino acids 32 to 58 Figure 5B, the amino terminus that includes amino acids 1-31, has a predominantly hydrophilic nature. As such, RNase 8 with this extension may not be a secretory protein. Unfortunately, despite significant effort and a recently developed specific anti-peptide antibody, we have been unable to detect expression of RNase 8 polypeptide in human fibroblast or hematopoietic cell lines. This may be due to the fact that expression levels at homeostasis are quite low Figure 2 and the appropriate conditions under which expression is augmented are not yet clear. Consistent with this finding, we have found that the natural construct, which includes the distal translational start site in tandem with the proximal translational start site, promotes only minimally activity Figure 5. The absence of an RNase 8 ortholog in laboratory rodent models adds to the limitations we are confronting.
Given these observations, taken together with our recent appreciation of the RNase A ribonuclease genes as scaffolds for evolutionary change [9, 10], it is apparent that we need to consider the possibility that RNase 8 is expressed as something other than a standard secretory ribonuclease; by extension, we need to revise the concept of functional pseudogenes. It is conceivable that RNase 8 is under constraints promoting selection of a novel function, perhaps only partially-related to its original role; as such, rigid adherence to the structure that is required for enzymatic cleavage of polymeric RNA is no longer necessary or useful. This and related hypotheses certainly merit further consideration.
Human genomic DNA samples and sequence analysis
Genomic DNA samples from human lymphocytes were obtained from the Coriell Institute for Medical Research (Camden, NJ). Additional samples of genomic DNA were obtained from normal volunteers after standard informed consent (protocol NIAID 09-I-0049). Table 1 includes sequences of all amplification, sequencing and mutagenesis primers. Briefly, 50 ng genomic DNA was used as an amplification target with 1 unit of Platinum Taq polymerase under standard conditions. Genomic DNAs, Taq proofreading polymerase, and gene-specific primers RN8F and RN8R primers were used to amplify a 688 bp genomic fragment encompassing the RNase 8 open reading frame. Amplification products were sequenced in both directions with BigDye terminator v3.1 on a 3130x Applied BioSystems sequencer using manufacturer's specifications. Heterozygosity was confirmed and resolved as necessary by cloning amplification products into TA vectors and re-sequencing.
Amplification of RNase 8 from primate genomic DNA
Primate genomic DNAs from Pan troglodytes, Gorilla gorilla, Pongo pygmaeus were obtained from BIOSLabs (New Haven, CT). Genomic DNA from Papio hamadryas was isolated from the 26CB-1 lymphoblast line (CRL-1495, American Type Culture Collection, Manassas, VA). Nested PCR was carried out via first round amplification using primers 5'-R8F and 3'-R8R; 0.5 μg of gDNA and 50X Titanium Taq polymerase were used to amplify the target gene with the cycling parameters including 95°C for 1 min followed by 30 cycles, 95°C for 30 sec, then 68°C 1.5 min, and 68°C for 3 min. The second nested amplification was performed to generate a ~ 625 bp product, also with Titanium Taq polymerase and primers 5'-R8Fn and 3'-R8Rn. Amplification products were cloned into TA 2.1 vector (Invitrogen) and multiple clones were sequenced in both directions using BigDye terminator v3.1 on a 3130x Applied Biosystems sequencer.
Database search and analysis of genome sequence data
Primate RNase 7 and RNase 8 sequences are located in the GenBank database under accession numbers AF473854-AF473863. Extended 5' coding sequences were identified in RNase 8s of both P. troglodytes and M. mulatta upon BLAST search of these full genome databases (Builds 2.1 and 1.1, respectively) accessed via the National Center for Bioinformatics (NCBI) website . Sequence alignments were generated with ClustalW  and analyzed with algorithms included within MEGA version 4.0 ( and DNAsp .
Rapid amplification of cDNA ends (RACE)
0.5 ng of human spleen marathon RACE-ready cDNA (Clontech) was amplified using the A2 polymerase kit (Clontech) and a 3' → 5' primer rcRN8 specific for RNase 8 and primary adapter primer as per manufacturer's instructions. The PCR cycling parameters were as follows: 94°C for 1 min followed by 40 cycles of 94°C for 30 sec and then 62°C for 2 min. 1 μL of amplified product was then used in a nested 5'RACE reaction targeting RNase8 using the nested 3' → 5' R85Rn gene-specific primer and nested adapter primer. The following cycling parameters were used for the nested RACE: 94°C for 1 min followed by 35 cycles of 94°C for 30 sec. and then 62°C for 2 min. This method yielded two amplification products, ~0.8 kb and ~1 kb, which were both cloned into TA 2.1 vectors; multiple clones were sequenced in both directions using BigDye terminator v3.1 on a 3130x Applied Biosystems sequencer according to manufacturer's instructions.
Reverse transcriptase polymerase chain reaction (RT-PCR) detection of RNase 8
Human spleen and placenta poly A+ RNA (Clontech) were used to generate cDNA with a 1st strand cDNA synthesis kit (Roche) following manufacturer's instructions. Briefly, 1 μg of RNA was DNase I-treated (Invitrogen) according to manufacturer's instructions; 100 ng of DNase-treated poly A+ RNA was reverse transcribed into cDNA using the following parameters: 25°C for 10 min, then 42°C for 60 min followed by 99°C for 5 min., and finally 4°C for 5 min. Control (no reverse transcriptase (RT)) samples were also generated. PCR amplification of RNase8S fragment was performed using cDNA from human spleen or placenta (or no RT controls), Titanium Taq polymerase kit, and primers R8S and R85R with the following cycling parameters: 95°C for 1 min, then 30 cycles of 95°C for 30 sec followed by 68°C 1.5 min., and finally 68°C for 3 min. From the RNase8S amplification product, nested PCR was performed using Titanium Taq polymerase and primers R8Sn and R85Rn which generated a ~544 bp fragment with the following cycling parameters 95°C for 1 min, 30 cycles, 95°C for 30 sec, 68°C 1.5 min, and 68°C for 3 min. The amplification products were cloned into TA 2.1 vector and multiple clones were sequenced in both directions using BigDye terminator v3.1 on a 3130x Applied Biosystems sequencer according to manufacturer's instructions.
Quantitative reverse-transcription polymerase chain reaction (qPCR) detection of RNase 8 expression in human tissue
Human and fetal tissue cDNA panels (Clontech) were screened using TaqMan universal PCR master mix and ABI 7500 Real Time PCR system according to manufacturer's instructions. The following primer/probe set was used to detect RNase 8,
primers, RNase 8fx, RNase 8rx; probe, 6FAM-RNase 8-TAMRA. The primer/probe set was specific for RNase 8, and did not detect RNase 7 plasmid DNA (data not shown). Each of the aforementioned tissue samples was evaluated in triplicate along with a single no-template control. qPCR screening by this method was also performed on human spleen and placenta cDNA generated from poly A+ RNA following the same procedure. Absolute quantities were determined by interpolation to a standard curve of 10 to 1010 copies RNase 8 coding sequence in the pCR 2.1 vector (Invitrogen), run in duplicate. Human GAPDH was detected via standard primer/probe set (Applied Biosystems) with absolute quantities determined by interpolation to a standard curve (nucleotides 41-1425 of the human GAPDH coding sequence, GenBank # NM_002046 cloned into pCR 2.1) run in duplicate.
RNase 8 expression plasmids, transfection and intracellular staining-flow cytometric analysis
RNase 8 expression constructs CCC3, CCC4 and CCC5 were prepared. CCC3 is a full length 595 bp RNase 8 open reading frame with both distal and proximal translational start sites and a carboxy-terminal FLAG (Figure 2). CCC4 is shortened 550 bp open reading frame that includes only the proximal translational start site. CCC5 is identical to CCC3 save for a point mutation that converts the methionine (ATG) in the proximal translational start site to an isoleucine. These open reading frames were cloned into the Hind III and Xho I restriction sites of expression plasmid pcDNA3.1 (Invitrogen) and purified (Origene) for transfection into COS-7 cells. COS-7 cells (ATCC CRL-1651) were seeded at a density of 3 × 106 cells per well in a six well plate 24 hours prior to transfection. 1 μg of DNA mixed with Lipofectamine 2000 reagent (Invitrogen) in a 1:3 ratio was added dropwise to each well. Six hours after addition of the transfection mixture, fresh media was added. 48 hours post-transfection, cells were removed from the plate with 0.05% Trypsin (Invitrogen) and 2 × 105 cells were added to a polystyrene tube (Falcon), fixed with 4% paraformaldehyde (Thermo Scientific), and washed 3 times with ice-cold 0.1% PBS/BSA. Cells were then washed 3 times with 0.1% PBS/Saponin solution and blocked with 5% milk in 0.1% PBS/saponin for 30 minutes on ice. After blocking, cells were stained with either rabbit anti-FLAG antibody conjugated to Alexa 647 (Cell Signaling) or anti-rabbit conjugated to Alexa 647 (Cell Signaling), both diluted 1:100 in 0.1% PBS/saponin for 30 minutes on ice. Cells were then washed 3 times in PBS/BSA 0.1% and one hundred thousand events were collected using an LSRII flow cytometer (BD Biosciences) and data collected was analyzed by FlowJo (Tree Star).
The Rosenberg laboratory has a longstanding interest in the evolution and function of secretory ribonucleases, most notably of the RNase A family.
List of Abbreviations
- RNase :
- SNP :
- RT-PCR :
reverse-transcriptase polymerase chain reaction
- RACE :
rapid amplification of cDNA ends
- ECP :
eosinophil cationic protein
- EDN :
- nt :
- bp :
We thank Dr. Todd Wilson, Ms. Daly Cantave, and Dr. Dean Metcalfe for use of the LAD/NIAID 09-I-0049 normal volunteer blood donor protocol. This work was supported by NIAID-DIR funding (Z01-AI00942).
- Beintema JJ: Introduction: the ribonuclease A superfamily. Cell Mol Life Sci. 1998, 54: 763-765. 10.1007/s000180050204.View ArticlePubMed
- Dyer KD, Rosenberg HF: (2006) The RNase A superfamily: generation of diversity and innate host defense. Mol Diversity. 2006, 10: 585-597. 10.1007/s11030-006-9028-2.View Article
- Rosenberg HF: RNase A ribonucleases and host defense: an evolving story. J Leukoc Biol. 2008, 83: 1079-1087. 10.1189/jlb.1107725.PubMed CentralView ArticlePubMed
- Cho S, Zhang J: Zebrafish ribonucleases are bactericidal: implications for the origin of the vertebrate RNase A superfamily. Mol Biol Evol. 2007, 24: 1259-1268. 10.1093/molbev/msm047.View ArticlePubMed
- Pizzo E, Varcamonti M, Di Maro A, Zanfardino A, Giancola C, D'Alessio G: Ribonucleases with angiogenic and bactericidal activities from the Atlantic salmon. FEBS J. 2008, 275: 1283-1295. 10.1111/j.1742-4658.2008.06289.x.View ArticlePubMed
- Penttinen J, Pujianto DA, Sipila P, Huhtaniemi I, Poutanen M: Discovery in silico and characterization in vitro of novel genes exclusively expressed in the mouse epididymis. Mol Endocrinol. 2003, 17: 2138-2151. 10.1210/me.2003-0008.View ArticlePubMed
- Cho S, Beintema JJ, Zhang J: The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. Genomics. 2005, 85: 208-220. 10.1016/j.ygeno.2004.10.008.View ArticlePubMed
- Rosenberg HF: Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity. J Biol Chem. 1995, 270: 7876-7881.View ArticlePubMed
- Nitto T, Dyer KD, Czapiga M, Rosenberg HF: Evolution and function of leukocyte RNase A ribonucleases of the avian species, Gallus gallus. J Biol Chem. 2006, 281: 25622-25634. 10.1074/jbc.M604313200.View ArticlePubMed
- Pizzo E, D'Alessio G: The success of the RNase scaffold in the advance of biosciences and in evolution. Gene. 2007, 406: 8-12. 10.1016/j.gene.2007.05.006.View ArticlePubMed
- Zhang J, Zhang YP, Rosenberg HF: Adaptive evolution of a duplicated pancreatic ribonuclease gene in a leaf-eating monkey. Nature Genetics. 2002, 30: 411-415. 10.1038/ng852.View ArticlePubMed
- D'Alessio G, Di Donato A, Parente A, Piccoli R: Seminal RNase: a unique member of the ribonuclease superfamily. Trends Biochem Sci. 1991, 16: 104-106.View ArticlePubMed
- Dubois JY, Catzeflis FM, Beintema JJ: The phylogenetic position of Acomyinae as sister group of Murinae and Gerbillinae clade: evidence from the nuclear ribonuclease gene. Mol Phylogenet Evol. 1999, 13: 181-192. 10.1006/mpev.1999.0674.View ArticlePubMed
- Rosenberg HF, Dyer KD, Tiffany HL, Gonzalez M: Rapid evolution of a unique family of primate ribonuclease genes. Nature Genetics. 1995, 10: 219-223. 10.1038/ng0695-219.View ArticlePubMed
- Zhang J, Rosenberg HF, Nei M: Positive Darwinian selection after gene duplication in primate ribonuclease genes. Proc Natl Acad Sci USA. 1998, 95: 3708-3713. 10.1073/pnas.95.7.3708.PubMed CentralView ArticlePubMed
- Zhang J, Dyer KD, Rosenberg HF: Evolution of the rodent eosinophil-associated RNase gene family by rapid gene sorting and positive selection. Proc Natl Acad Sci (USA). 2000, 97: 4701-4706. 10.1073/pnas.080071397.PubMed CentralView Article
- Harder J, Schröder JM: RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem. 2002, 277: 46779-467784. 10.1074/jbc.M207587200.View ArticlePubMed
- Zhang J, Dyer KD, Rosenberg HF: Human RNase 7: a new cationic ribonuclease of the RNase A superfamily. Nucl Acids Res. 2003, 31: 602-607. 10.1093/nar/gkg157.PubMed CentralView ArticlePubMed
- Harder J, Schröder JM: Antimicrobial peptides in human skin. Chem Immunol Allergy. 2005, 86: 22-41.View ArticlePubMed
- Koten B, Simanski M, Glaser R, Podschun R, Schröder JM, Harder J: RNase 7 contributes to the cutaneous defense against Enterococcus faecium. PloS One. 2009, 4: e6424-10.1371/journal.pone.0006424.PubMed CentralView ArticlePubMed
- Zanger P, Holzer J, Schleucher R, Steffen H, Schittek B, Gabrysch S: Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin. J Infect Dis. 2009, 200: 1907-1915. 10.1086/648408.View ArticlePubMed
- Gambichler T, Skrygan M, Tomi H, Othlinghaus N, Brockmeyer NH, Altmeyer P, Kreuter A: Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol. 2008, 147: 17-24. 10.1159/000128582.View ArticlePubMed
- Huang YC, Lin YM, Chang TW, Wu SJ, Lee YS, Chang MD, Chen C, Wu SH, Liao YD: The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity. J Biol Chem. 2007, 282: 4626-4633.View ArticlePubMed
- Lin YM, Wu SJ, Chang TW, Wang CF, Suen CS, Hwang MJ, Chang MD, Chen YT, Liao YD: Outer membrane protein I of Pseudomonas aeruginosa is a target of cationic antimicrobial peptide/protein. J Biol Chem. 2010, 285: 8985-8994. 10.1074/jbc.M109.078725.PubMed CentralView ArticlePubMed
- Zhang J, Dyer KD, Rosenberg HF: RNase 8, a novel RNase A superfamily ribonuclease expressed uniquely in placenta. Nucl Acids Res. 2002, 30: 1169-1175. 10.1093/nar/30.5.1169.PubMed CentralView ArticlePubMed
- Zhang J: Disulfide-bond reshuffling in the evolution of an ape placental ribonuclease. Mol Biol Evol. 2007, 24: 505-512.View ArticlePubMed
- Zhang J, Rosenberg HF: Diversifying selection of the tumor-growth promoter angiogenin in primate evolution. Mol Biol Evol. 2002, 19: 438-445. 10.1093/oxfordjournals.molbev.a004099.View ArticlePubMed
- Deming MS, Dyer KD, Bankier AT, Piper MB, Dear PH, Rosenberg HF: Ribonuclease k6: chromosomal mapping and divergent rates of evolution within the RNase A gene superfamily. Genome Res. 1998, 8: 599-607.PubMed
- National Center for Biotechnology Information (NCBI). [http://www.ncbi.nlm.nih.gov/]
- ExPasy/Kyte-Doolittle. [http://www.expasy.ch/cgi-bin/protscale.pl]
- Li W-H, Sadler LA: Low nucleotide diversity in man. Genetics. 1991, 129: 519-523.
- Zhang J, Rosenberg HF: Sequence variation at two eosinophil-associated ribonuclease loci in humans. Genetics. 2000, 156: 1949-1958.PubMed CentralPubMed
- MacDonald RJ, Stary SJ, Swift GH: (1982) Rat pancreatic ribonuclease messenger RNA: the nucleotide sequence of the entire mRNA and the derived amino acid sequence of the pre-enzyme. J Biol Chem. 1982, 257: 14582-14585.PubMed
- ClustalW. [http://clustalw.genome.jp]
- Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007, 24: 1596-1599. 10.1093/molbev/msm092. [http://www.megasoftware.net]View ArticlePubMed
- DNAsp. [http://www.ub.es/dnasp]
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.